For research use only. Not for therapeutic Use.
PRIMA-1 (Cat No.:I004093) is a potent activator of p53 mutants, which are commonly found in various types of human tumors. It exerts its therapeutic effects by restoring the normal function of mutant p53, a crucial tumor suppressor protein. By doing so, PRIMA-1 induces apoptosis, or programmed cell death, in tumor cells carrying p53 mutations, effectively inhibiting tumor growth. This compound holds promise as a targeted therapy for cancers with p53 mutations, providing a potential strategy to combat tumor progression and improve treatment outcomes.
Catalog Number | I004093 |
CAS Number | 5608-24-2 |
Synonyms | 2,2-bis(hydroxymethyl)-1-azabicyclo[2.2.2]octan-3-one |
Molecular Formula | C9H15NO3 |
Purity | ≥95% |
Target | Apoptosis |
Solubility | DMSO: ≥ 44 mg/mL |
Storage | 2-8°C |
IUPAC Name | 2,2-bis(hydroxymethyl)-1-azabicyclo[2.2.2]octan-3-one |
InChI | InChI=1S/C9H15NO3/c11-5-9(6-12)8(13)7-1-3-10(9)4-2-7/h7,11-12H,1-6H2 |
InChIKey | RFBVBRVVOPAAFS-UHFFFAOYSA-N |
SMILES | C1CN2CCC1C(=O)C2(CO)CO |